Lexaria Bioscience (LEXX) Insider Trading & Ownership $0.83 +0.00 (+0.48%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience (NASDAQ:LEXX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.40%Number OfInsiders Buying(Last 12 Months)6Amount OfInsider Buying(Last 12 Months)$105.21KNumber OfInsiders Selling(Last 12 Months)0 Get LEXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexaria Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LEXX Insider Buying and Selling by Quarter Lexaria Bioscience Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/30/2025Christopher BunkaDirectorBuy11,900$0.91$10,829.00 7/29/2025Christopher BunkaDirectorBuy15,600$0.92$14,352.00 7/29/2025John Martin DochertyInsiderBuy5,376$0.93$4,999.68 7/29/2025Richard ChristopherCEOBuy15,000$0.91$13,650.00 7/29/2025Vanessa CarleInsiderBuy750$0.91$682.50 7/29/2025William Edward MckechnieDirectorBuy5,000$0.91$4,550.00 12/2/2024Richard ChristopherCEOBuy22,828$2.24$51,134.72 8/12/2024Catherine C TurkelDirectorBuy1,600$3.13$5,008.00 (Data available from 1/1/2013 forward) LEXX Insider Trading Activity - Frequently Asked Questions Who is on Lexaria Bioscience's Insider Roster? The list of insiders at Lexaria Bioscience includes Catherine C Turkel, Christopher Bunka, John Martin Docherty, Richard Christopher, Vanessa Carle, and William Edward Mckechnie. Learn more on insiders at LEXX. What percentage of Lexaria Bioscience stock is owned by insiders? 26.40% of Lexaria Bioscience stock is owned by insiders. Learn more on LEXX's insider holdings. Which Lexaria Bioscience insiders have been buying company stock? The following insiders have purchased LEXX shares in the last 24 months: Catherine C Turkel ($5,008.00), Christopher Bunka ($25,181.00), John Martin Docherty ($4,999.68), Richard Christopher ($64,784.72), Vanessa Carle ($682.50), and William Edward Mckechnie ($4,550.00). How much insider buying is happening at Lexaria Bioscience? Insiders have purchased a total of 78,054 LEXX shares in the last 24 months for a total of $105,205.90 bought. Which Lexaria Bioscience insiders have been selling company stock? The following insider sold LEXX shares in the last 24 months: Vanessa Carle ($10,268.00). How much insider selling is happening at Lexaria Bioscience? Insiders have sold a total of 2,567 Lexaria Bioscience shares in the last 24 months for a total of $10,268.00 sold. Lexaria Bioscience Key ExecutivesMr. Christopher A. Bunka (Age 62)Chairman & CEO Compensation: $291.19k2 recent tradesMr. John M. Docherty M.Sc. (Age 55)President & Director Compensation: $290.46kMr. Nelson D. Cabatuan CPA (Age 45)Chief Financial Officer Kristin HamiltonDirector of OperationsVanessa CarleHead of Legal1 recent tradesDr. Philip N. Ainslie Ph.D.Advisor & Consultant More Insider Trading Tools from MarketBeat Related Companies Oncobiologics Insider Ownership VolitionRx Insider Ownership Repare Therapeutics Insider Ownership Opus Genetics Insider Ownership Context Therapeutics Insider Ownership Forte Biosciences Insider Ownership Invizyne Technologies Insider Ownership Applied Therapeutics Insider Ownership INmune Bio Insider Ownership Biomea Fusion Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:LEXX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
